Gastrointestinal (GI) Clinical Trial Program

A Phase II/III trial of Neoadjuvant FOLFOX, with selective use of combined modality Chemoradiation versus preoperative combined modality Chemoradiation for locally advanced Rectal Cancer patients undergoing low anterior resection with total Mesorectal Excision
Familial Colorectal Registry
Familial Colorectal Cancer Registry Program

To access the full protocols, please contact:
Rita McTighe, Oncology Clinical Research Coordinator, at or call (732) 923-6564.